Edgewise Therapeutics EWTX
NASDAQ EWTX
$40.35 -0.25 (-0.62%)
As of: Oct 1, 2026 · 12:31 PM EDT

Edgewise Therapeutics (EWTX) Other financing activities (2022 - 2025)

Updated

Edgewise Therapeutics' Other financing activities came in at $38,000 for Q1 2025.

Analysis

Edgewise Therapeutics (EWTX) Other financing activities (2022 - 2025) Analysis & Trends

Over the trailing twelve months to Mar 31, 2025, Edgewise Therapeutics reported Other financing activities of $203,000; for FY2024, it was $262,000, up 58.8% from FY2023.

  • Going back by year, Other financing activities was $165,000 in FY2023 (-34.3%) and $251,000 in FY2022.
  • The Q1 2025 figure represents the lowest quarterly Other financing activities since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Edgewise Therapeutics 4.38 Bn 4.38 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 38,000.00
Sep 30, 2024 214,000.00
Dec 31, 2023 -49,000.00
Dec 31, 2022 -85,000.00
Sep 30, 2022 82,000.00
API Access

Edgewise Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=EWTX&period=max&api_key=YOUR_API_KEY